IKZF1 as a novel marker of minimal residual disease in patients with acute lymphoblastic leukaemia

被引：0
|
作者：
Barkhatov, M. [1 ]
Lebedinova, N. [1 ]
Zagrivnaya, M. [1 ]
Semenova, E. [1 ]
Zubarovskaya, L. [1 ]
Afanasyev, B. [1 ]
机构：
[1] Pavlov State Med Univ St Petersburg, St Petersburg, Russia
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S247 / S248
页数：2
相关论文
共 50 条
  • [31] HDACi Targets IKZF1 Deletion High-Risk Acute Lymphoblastic Leukemia By Inducing IKZF1 Expression and Rescuing IKZF1 Function in Vitro and In Vivo
    Huang, Kangyu
    Tang, Bingqing
    Cai, Zihong
    He, Xianjun
    Li, Qiuli
    Liu, Nannan
    Lin, Dainan
    Pan, Xinhua
    Shi, Ce
    Long, Zijie
    Wang, Jinheng
    Hu, Yumin
    Li, Peng
    Liu, Qifa
    Zhou, Hongsheng
    BLOOD, 2021, 138
  • [32] Unravelling the prognostic effect of IKZF1 deletions and IGH@-CRLF2 in adult acute lymphoblastic leukaemia
    O'Reilly, John
    Russell, Lisa J.
    Cooney, Julian
    Ensor, Hannah M.
    Purtill, Duncan
    Wright, Matthew
    Moorman, Anthony V.
    PATHOLOGY, 2013, 45 (06) : 609 - 612
  • [33] IKZF1 PLUS PROFILE AND OUTCOME ANALYSIS IN A COHORT OF PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA
    Singh, Minu
    Bhatia, Prateek
    Trehan, Amita
    Hc, Pragna
    Thakur, Rozy
    Varma, Neelam
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [34] Quantitative detection of IKZF1 deletion by digital PCR in patients with acute lymphoblastic leukemia
    Hashiguchi, Junichi
    Onozawa, Masahiro
    Okada, Kohei
    Amano, Toraji
    Hatanaka, Kanako C.
    Nishihara, Hiroshi
    Sato, Norihiro
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (02) : E38 - E40
  • [35] IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly
    Vairy, Stephanie
    Thai Hoa Tran
    BLOOD REVIEWS, 2020, 44
  • [36] The Interplay Between IKZF1 and COBL Deletions in Acute Lymphoblastic Leukemia
    Lopes, B.
    Meyer, C.
    Barbosa, T.
    Poubel, C.
    Mansur, M.
    Duployez, N.
    Palmi, C.
    Cazzaniga, G.
    Bashton, M.
    Harrison, C.
    Alonso, C.
    Tsaur, G.
    Gupta, S.
    zur Stadt, U.
    Venn, N.
    Sutton, R.
    Pombo-de-Oliveira, M. S.
    Marschalek, R.
    Emerenciano, M.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S135 - S136
  • [37] The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia
    Moppett, J
    Burke, GAA
    Steward, CG
    Oakhill, A
    Goulden, NJ
    JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (04) : 249 - 253
  • [38] Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia
    Goulden, N
    Oakhill, A
    Steward, C
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (02) : 275 - 281
  • [39] Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
    Eckert, C
    Biondi, A
    Seeger, K
    Cazzaniga, G
    Hartmann, R
    Beyermann, B
    Pogodda, M
    Proba, J
    Henze, G
    LANCET, 2001, 358 (9289): : 1239 - 1241
  • [40] IKZF1 Status As an Independent Prognostic Marker in Adult Common B-Cell Acute Lymphoblastic Leukemia
    Yao, Qiumei
    Liu, Kaiyan
    Jiang, Bing
    Liu, Yanrong
    Jiang, Qian
    Jiang, Hao
    Zhang, Xiaohui
    Chen, Shanshan
    Huang, Xiaojun
    Xu, Lanping
    Ruan, Guorui
    BLOOD, 2014, 124 (21)
12345